The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Transcranial Magnetic Stimulation.
- Who it may be relevant to
- Registry conditions: Insomnia Chronic, Narcolepsy, REM Sleep Behavior Disorder. Basic parameters: 8 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Carry out precise and effective neuromodulation interventions, and develop new neuromodulation technologies for sleep disorders. Use phototherapy, transcranial electrical/magnetic stimulation and other therapies to conduct self-controlled intervention studies on insomnia, narcolepsy, and rapid eye movement sleep behavior disorder .
Interventions
- Device Transcranial Magnetic Stimulation
repetitive transcranial magnetic stimulation, or transcranial direct current stimulation, or daytime timed bright light exposure
Primary outcome measures
- Objective sleep indicators and clinical sleep-related scales [Time frame: From enrollment to the end of treatment at 4 weeks]
Secondary outcome measures (1)
- Resting-state electroencephalogram, resting-state functional magnetic resonance imaging, blood biochemical indicators [Time frame: From enrollment to the end of treatment at 4 weeks]
Eligibility criteria
Inclusion criteria
\- Patients with insomnia, narcolepsy,and RBD that have been clearly diagnosed by specialists should sign the informed consent form.
Exclusion criteria
- Patients with major neurological diseases such as multi-infarct dementia, Huntington\'s disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or those who have sustained neurological dysfunction or known structural brain abnormalities after significant head trauma are excluded.
- A history of major depressive disorder or bipolar disorder within the past year, as defined in DSM-IV criteria. A history of schizophrenia (meeting DSM-IV criteria).
- History of severe drug or alcohol abuse within the past year;
- Any significant systemic illness or unstable medical condition that may make it difficult to comply with the protocol, such as severe autoimmune diseases or a history of cancer.
- Have significant hearing, visual, or cognitive impairments, or are unable to participate in interviews in a meaningful way.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
China · 1 center
- Department of Neurology, Second Affiliated Hospital of Soochow University — Suzhou
Identifiers
NCT: NCT06797284 · LK2024002